Trading Signals: ADAP Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Fri. May. 28, 2021)(Adaptimmune Therapeutics plc)
| ADAP latest price $5.7400 (3.14%) ($5.7400 - $5.7400) on Mon. Jan. 25, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.61% (three month average) | RSI | 47 | Latest Price | $5.7400(3.14%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ADAP declines -2% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ADAP advance at 0% a week (0% probability) IGOV(85%) IFRA(47%) PAVE(40%) XME(40%) BLOK(39%) | Factors Impacting ADAP price | ADAP will decline at least -2.305% in a week (0% probabilities). TLT(-23%) VXX(-19%) VCIT(-17%) UUP(-10%) TIP(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.305% (StdDev 4.61%) | Hourly BBV | 0.8 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $5.69(0.88%) | 10 Day Moving Average | $5.81(-1.2%) | 20 Day Moving Average | $5.71(0.53%) | To recent high | -7.6% | To recent low | 14.2% | Market Cap | $887m | | | | Adaptimmune Therapeutics Plc engages in the development of novel cancer immunotherapy products. Its specific peptide enhanced affinity receptor platform enables the engineering of T-cells to target and destroy cancer, including solid tumors. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom. |